GlassScriptPhysician profile
Kurt John Kitziger
NPI 1457467789
$1,639.01
in general payments reported to CMS, 2019-2025
11 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2021: $26.19 · 2022: $63.78 · 2023: $210 · 2024: $41.54 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,013.57 | 2019-2025 | Mako |
| Ferring Pharmaceuticals INC. | $223.99 | 2019-2025 | Euflexxa |
| Heron Therapeutics, INC. | $142.65 | 2025 | Zynrelef |
| Orthalign INC | $111.18 | 2019 | |
| Pylant Medical | $30.53 | 2023 | |
| Depuy Synthes Sales INC. | $26.28 | 2021-2024 | Monovisc, Orthovisc |
| Orthofix Medical, INC. | $22.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $22.62 | 2019 | |
| Amgen INC. | $17.71 | 2025 | Evenity |
| Medical Device Business Services, INC. | $14.50 | 2021 | |
| Horizon Therapeutics Plc | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Kitziger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.